Comparison study of different indoleamine-2,3 dioxygenase inhibitors from the perspective of pharmacodynamic effects

INTRODUCTION: Indoleamine 2,3-dioxygenase (IDO) was a potential tumor immunotherapy target. IDO inhibitors showed inconsistent results in clinical trials, but no preclinical comparative study was reported. The purpose of this study was to evaluate the differences of representative IDO inhibitors (PC...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Xue, Li, Xiaopeng, Zheng, Shuang, Du, Guangying, Ma, Jinbo, Zhang, Liming, Wang, Hongbo, Tian, Jingwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7517983/
https://www.ncbi.nlm.nih.gov/pubmed/32962460
http://dx.doi.org/10.1177/2058738420950584

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7517983/
https://www.ncbi.nlm.nih.gov/pubmed/32962460
http://dx.doi.org/10.1177/2058738420950584

Ejemplares similares